(AQP) Aquaporin AS - Ratings and Ratios

Exchange: CO • Country: Denmark • Currency: DKK • Type: Common Stock • ISIN: DK0061555109

AQP: Membranes, Modules, Purification Systems, Filtration Elements

Aquaporin A/S is a water technology company specializing in innovative solutions for clean drinking water. Headquartered in Kongens Lyngby, Denmark, the company operates globally, with a presence in Denmark, China, Singapore, Turkey, and the United States. Aquaporin develops and markets advanced water purification systems, including drinking water membranes, hollow fiber forward osmosis modules, and brackish water reverse osmosis elements under the CLEAR brand. These products serve various industries, including drinking water, industrial water, hemodialysis, and food and beverage sectors. Since its incorporation in 2005, Aquaporin has focused on leveraging biotechnology and membrane engineering to improve water treatment efficiency and sustainability. Web URL: https://www.aquaporin.com

From a financial perspective, Aquaporin A/S (Ticker: AQP) is listed on the CO exchange as a common stock. The company operates within the Water Utilities sub-industry, with a market capitalization of 423.29M DKK. Key financial metrics include a price-to-book ratio of 1.71 and a price-to-sales ratio of 6.18, indicating moderate valuation levels. The return on equity stands at -35.80, reflecting current profitability challenges. On the technical side, the stock has shown recent price stability, with a 20-day average volume of 4,636 shares and a last price of 18.90 DKK. Moving averages indicate a neutral trend, with SMA 20 at 18.79, SMA 50 at 19.00, and SMA 200 at 21.93. The average true range (ATR) of 1.13 suggests moderate volatility.

3-Month Forecast: Based on the provided technical and fundamental data, Aquaporin A/S is expected to experience: - Price Stability: The stock is likely to trade within a narrow range, with support around 18.00 DKK and resistance near 20.00 DKK. - Volume Trends: Average daily volume may remain low, around 4,000-5,000 shares, indicating limited market activity. - Valuation Adjustments: With a P/S ratio of 6.18, the stock may face downward pressure if revenue growth does not accelerate. - Profitability Focus: The companys negative return on equity (-35.80) suggests operational challenges that could impact investor sentiment in the near term.

Additional Sources for AQP Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

AQP Stock Overview

Market Cap in USD 52m
Sector Utilities
Industry Utilities - Regulated Water
GiC Sub-Industry Water Utilities
IPO / Inception

AQP Stock Ratings

Growth Rating -67.6
Fundamental -
Dividend Rating 0.0
Rel. Strength -21
Analysts -
Fair Price Momentum 8.04 DKK
Fair Price DCF -

AQP Dividends

No Dividends Paid

AQP Growth Ratios

Growth Correlation 3m -95.7%
Growth Correlation 12m -21.6%
Growth Correlation 5y -94.7%
CAGR 5y -48.27%
CAGR/Max DD 5y -0.52
Sharpe Ratio 12m -0.94
Alpha -29.81
Beta 1.680
Volatility 57.08%
Current Volume 11.6k
Average Volume 20d 6.7k
What is the price of AQP stocks?
As of May 05, 2025, the stock is trading at DKK 13.45 with a total of 11,566 shares traded.
Over the past week, the price has changed by -3.93%, over one month by +1.13%, over three months by -28.84% and over the past year by -5.61%.
Is Aquaporin AS a good stock to buy?
No, based on ValueRay Analyses, Aquaporin AS (CO:AQP) is currently (May 2025) a stock to sell. It has a ValueRay Growth Rating of -67.58 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AQP as of May 2025 is 8.04. This means that AQP is currently overvalued and has a potential downside of -40.22%.
Is AQP a buy, sell or hold?
Aquaporin AS has no consensus analysts rating.
What are the forecast for AQP stock price target?
According to ValueRays Forecast Model, AQP Aquaporin AS will be worth about 9.7 in May 2026. The stock is currently trading at 13.45. This means that the stock has a potential downside of -28.25%.
Issuer Forecast Upside
Wallstreet Target Price 25 85.9%
Analysts Target Price - -
ValueRay Target Price 9.7 -28.3%